https://www.pharma-food.de/curevac-kuendigt-die-produktionsvertraege-mit-wacker-und-celonic/2303740
Curevac kündigt die Produktionsverträge mit Wacker und Celonic
Sep 16, 2021 - Curevac passt nach den enttäuschenden Ergebnissen seines mRNA-Impfstoffkandidaten nun auch das Produktionsnetzwerk an: Die Verträge mit Wacker und Celonic...
curevacdiemitwackerund
https://www.epo.org/fr/boards-of-appeal/decisions/t241407eu1
T 1407/24 (Method of increasing the replication of a circular DNA molecule/CUREVAC REAL ESTATE) du...
circular dnareal estatemethodincreasingreplication
https://www.fidelity.co.uk/shares/stock-market-news/company-news/gsk-and-curevac-secure-740m-payout-in-mrna-patent-settlement/?articleid=35273794&categoryid=0100,0101,0102,0103,0104,0105,0106,0107,0108,0109,0110,0111,0112,0113,0199
GSK and CureVac secure $740m payout in mRNA patent settlement
gskcurevacsecurepayoutmrna
https://www.lifesciencesipreview.com/americas/curevac-targets-moderna-with-10-patent-suit-over-spikevax
CureVac targets Moderna with 10-patent suit over Spikevax | Americas | Life Sciences Intellectual...
CureVac targets Moderna with 10-patent suit over Spikevax
life sciencescurevactargetsmodernapatent
https://dorzeczy.pl/swiat/172324/ema-rozpoczela-przeglad-etapowy-dla-szczepionki-firmy-curevac.html
EMA rozpoczęła przegląd etapowy dla szczepionki firmy CureVac
Feb 12, 2021 - Europejska Agencja Leków (EMA) rozpoczęła tzw. przegląd etapowy dla szczepionki przeciwko COVID-19 firmy CureVac – poinformował w piątek prezes URPL Grzegorz...
emadlaszczepionkifirmycurevac
https://baertigerwolf.de/curevac
Die Boten des Neuen - CureVac / Bär Tiger Wolf
tiger wolfdiebotendesneuen
https://ygeia50plus.gr/news/bayer-curevac-ypopsifio-embolio-sti-maxi-kata-tis-loimvjhs-covid-19/
Bayer- CureVac: Υποψήφιο νέο εμβόλιο στη μάχη κατά της λοίμωξης Covid-19. | Ygeia50plus
bayercurevaccovid
https://www.farmacovigilanzasardegna.it/2021/02/16/ema-avvia-la-revisione-ciclica-del-vaccino-anti-covid-19-di-curevac-cvncov/
EMA avvia la revisione ciclica del vaccino anti-COVID-19 di CureVac (CVnCoV) – Centro Regionale...
Feb 16, 2021 - Notizie sulla sicurezza del farmaco.
emaavviarevisioneciclicadel
https://www.ccp4.ac.uk/job/postdoctoral-researcher-at-lund-medical-faculty-curevac-institut-laue-langevin/
Postdoctoral researcher at Lund Medical Faculty/CureVac/Institut Laue-Langevin – Collaborative...
institut laue langevinpostdoctoral researchermedical facultylundcurevac
https://www.infobae.com/america/mundo/2021/01/07/los-alemanes-bayer-y-curevac-unieron-sus-fuerzas-para-acelerar-la-autorizacion-de-una-de-las-vacunas-mas-esperadas-contra-el-coronavirus/
Los alemanes Bayer y CureVac unieron sus fuerzas para acelerar la autorización de una de las...
Jan 7, 2021 - La biotecnológica alemana, que anunció recientemente su ensayo clínico de fase 2b/3 de su vacuna candidata contra la covid-19, alcanzó un acuerdo con el...
de unalosalemanesbayercurevac
https://www.bioregio-stern.de/en/news/curevac-announces-resolution-of-patent-litigation-with-pfizerbiontech
CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech | BioRegio STERN |...
CureVac N.V. (Nasdaq: CVAC), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today...
patent litigationcurevacannouncesresolutionpfizer